Sunshine Biopharma, Inc.
SBFM
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.52% | -20.07% | -16.38% | -41.81% | -71.39% |
| Total Depreciation and Amortization | 30.88% | 40.05% | 48.55% | 49.03% | 54.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.26% | -- | 14,554.17% | 12,936.29% | 8,748.33% |
| Change in Net Operating Assets | 76.59% | 71.96% | 81.28% | 61.21% | 62.88% |
| Cash from Operations | 31.00% | 48.44% | 57.59% | 39.87% | 29.14% |
| Capital Expenditure | 97.57% | 89.25% | 89.47% | 76.27% | -18.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.16% | -924.18% | -134.63% | 27.41% | 6.67% |
| Cash from Investing | 81.83% | 45.93% | 52.98% | 54.51% | -4.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 29.73% | 155.07% | -- | 329.48% | 148.34% |
| Issuance of Common Stock | 13.15% | 13.54% | -60.70% | -46.09% | -12.04% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.27% | 14.62% | -46.05% | -21.60% | 43.99% |
| Foreign Exchange rate Adjustments | -2.53% | 227.83% | 182.03% | -2,049.64% | 141.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 386.34% | 86.99% | 91.47% | 56.32% | 85.38% |